Dubik, M.; Marczynska-Grzelak, J.; Sørensen, M.Z.; Dieu, R.S.; Rusin, D.; Schiöth, E.S.; Ramazani, B.; Belal, R.; Ojha, B.; Krieger, J.;
et al. Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis. Int. J. Mol. Sci. 2024, 25, 7462.
https://doi.org/10.3390/ijms25137462
AMA Style
Dubik M, Marczynska-Grzelak J, Sørensen MZ, Dieu RS, Rusin D, Schiöth ES, Ramazani B, Belal R, Ojha B, Krieger J,
et al. Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis. International Journal of Molecular Sciences. 2024; 25(13):7462.
https://doi.org/10.3390/ijms25137462
Chicago/Turabian Style
Dubik, Magdalena, Joanna Marczynska-Grzelak, Michael Zaucha Sørensen, Ruthe Storgaard Dieu, Dominika Rusin, EydÃs Sigurdardóttir Schiöth, Bita Ramazani, Rouhin Belal, Bhavya Ojha, Jonathan Krieger,
and et al. 2024. "Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis" International Journal of Molecular Sciences 25, no. 13: 7462.
https://doi.org/10.3390/ijms25137462
APA Style
Dubik, M., Marczynska-Grzelak, J., Sørensen, M. Z., Dieu, R. S., Rusin, D., Schiöth, E. S., Ramazani, B., Belal, R., Ojha, B., Krieger, J., Arengoth, D. S., Wlodarczyk, A., Owens, T., & Khorooshi, R.
(2024). Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis. International Journal of Molecular Sciences, 25(13), 7462.
https://doi.org/10.3390/ijms25137462